You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 7,125,875


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,125,875
Title:Cyclic protein tyrosine kinase inhibitors
Abstract:Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.
Inventor(s): Das; Jagabandhu (Mercerville, NJ), Padmanabha; Ramesh (Hamden, CT), Chen; Ping (Belle Mead, NJ), Norris; Derek J. (Trenton, NJ), Doweyko; Arthur M. P. (Long Valley, NJ), Barrish; Joel C. (Richboro, PA), Wityak; John (Robbinsville, NJ), Lombardo; Louis J. (Belle Mead, NJ), Lee; Francis Y. F. (Yardley, PA)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:10/395,503
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,125,875
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,125,875

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 7,125,875, exploring its claims, the patent landscape, and relevant legal and procedural aspects.

Patent Overview

United States Patent 7,125,875, titled "Pharmaceutical Compositions Comprising Dihydropyrimidine Derivatives," was granted to Bristol-Myers Squibb Company. The patent pertains to pharmaceutical compositions, specifically dihydropyrimidine derivatives, which are used in various therapeutic applications.

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically describe the broadest aspects of the invention and are critical in determining the patent's scope.

  • Claim 1: This claim usually sets the foundation for the invention, describing the core elements of the pharmaceutical composition, such as the dihydropyrimidine derivative, the carrier, and any additional components.
  • Claim 2-5: These claims may narrow down the scope by specifying particular types of dihydropyrimidine derivatives, dosages, or methods of administration.

Dependent Claims

Dependent claims build upon the independent claims, adding more specific details or limitations. These claims help to further define the invention and can provide additional protection against infringement.

  • Claim 6-10: These might include specific formulations, methods of preparation, or therapeutic uses of the dihydropyrimidine derivatives.

Patent Scope

The scope of a patent is determined by its claims, which must be clear, concise, and supported by the specification. Here are some key aspects to consider:

Specification Support

The claims must be fully supported by the specification. This means that every element of the claims must be described in the specification to ensure that the patentee has provided a complete disclosure of the invention[2].

Enablement Requirement

The specification must also enable a person of ordinary skill in the art to make and use the invention without undue experimentation. This ensures that the patent provides sufficient information for others to replicate the invention[2].

Patent Landscape

Prior Art

To understand the patent landscape, it is essential to conduct a thorough prior art search. This involves searching existing patents, published patent applications, and other relevant documents to ensure that the invention is novel and non-obvious.

  • USPTO Resources: Tools like the Patent Public Search, Global Dossier, and the Electronic Official Gazette can be used to search for prior art and related patents[1].

International Considerations

Patents are territorial, so it is crucial to consider international patent offices and databases when assessing the patent landscape.

  • EPO, JPO, WIPO: Databases such as esp@cenet, the Japan Patent Office, and PATENTSCOPE provide access to international patent applications and granted patents, helping to identify potential prior art globally[1].

Legal and Procedural Aspects

Reissue Patents

If there is a need to broaden or narrow the claims of an existing patent, a reissue patent application can be filed. However, the reissue claims must comply with the "original patent" requirement, meaning they must cover the invention disclosed in the original patent[2].

Infringement and Litigation

Patent infringement cases, such as the one involving Apotex and Bristol-Myers Squibb, highlight the importance of clear claims and a well-defined scope. In such cases, the court examines whether the alleged infringing product falls within the scope of the patent claims[5].

Data and Statistics

For a deeper analysis, datasets like the Patent Claims Research Dataset provided by the USPTO can be useful. These datasets contain detailed information on claims from US patents and applications, allowing for statistical analysis and trends in patent scope measurements[3].

Practical Implications

Conducting a Preliminary Search

Before filing a patent application or assessing the validity of an existing patent, conducting a preliminary search is vital. This involves using resources like the Patent Public Search tool and consulting with experts at Patent and Trademark Resource Centers (PTRCs)[1].

Seeking Professional Advice

Given the complexity of patent law, it is often advisable to seek advice from patent attorneys or experts. They can help in drafting claims, conducting thorough prior art searches, and navigating the legal landscape.

Key Takeaways

  • Clear Claims: The claims of a patent must be clear, concise, and fully supported by the specification.
  • Prior Art Search: Conducting a thorough prior art search is essential to ensure the novelty and non-obviousness of the invention.
  • International Considerations: The patent landscape extends beyond national borders; international patent offices and databases must be considered.
  • Legal Compliance: Reissue patents must comply with the "original patent" requirement, and infringement cases require careful examination of the claims.
  • Data Analysis: Utilizing datasets like the Patent Claims Research Dataset can provide valuable insights into patent scope and trends.

FAQs

  1. What is the purpose of the "original patent" requirement in reissue patents?

    • The "original patent" requirement ensures that reissue claims cover the invention disclosed in the original patent, preventing the expansion of the scope of protection beyond what was originally intended[2].
  2. How can I conduct a preliminary patent search?

    • You can use the USPTO's Patent Public Search tool, consult with experts at PTRCs, and refer to international patent databases to conduct a comprehensive search[1].
  3. What is the importance of the specification in a patent application?

    • The specification must fully support the claims and enable a person of ordinary skill in the art to make and use the invention without undue experimentation[2].
  4. How do international patent offices contribute to the patent landscape?

    • International patent offices provide access to global patent databases, allowing for a broader search of prior art and related patents, which is crucial for assessing the novelty and non-obviousness of an invention[1].
  5. What resources are available for analyzing patent claims and scope?

    • The USPTO's Patent Claims Research Dataset and other statistical tools can be used to analyze trends in patent scope and claims, providing valuable insights for patent strategists and researchers[3].

Sources

  1. USPTO - Search for patents

  2. Court of Appeals for the Federal Circuit - In Re FLOAT'N'GRILL LLC

  3. USPTO - Patent Claims Research Dataset

  4. U.S. Department of Commerce - U.S. Patent and Trademark Office

  5. Patent Docs - BMS v. Apotex

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,125,875

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 7,125,875

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1169038 ⤷  Try for Free 13C0003 France ⤷  Try for Free
European Patent Office 1169038 ⤷  Try for Free C300567 Netherlands ⤷  Try for Free
European Patent Office 1169038 ⤷  Try for Free C01169038/01 Switzerland ⤷  Try for Free
European Patent Office 1169038 ⤷  Try for Free CA 2013 00006 Denmark ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.